Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fate Therapeutics, Inc. - Common Stock (NQ:FATE)

0.9832 -0.0168 (-1.68%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Fate Therapeutics, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
3 Biotech Stocks to Watch Now ↗
Biotech companies develop new medicines, vaccines, or medical devices. They use advanced technologies and medical science to do so. Most biotech stocks trade at low prices and... 
Via Benzinga
News headline image
Recent Poor Results Have Made This Promising Cathie Wood Pick a Bargain ↗
Positive news versus poor clinical trial results may determine the future of Fate Therapeutics. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2021 ↗
Upgrades Scotiabank upgraded the previous rating for Enerplus Corp (NYSE: 
Via Benzinga
News headline image
58 Biggest Movers From Friday ↗
Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares climbed 204.1% to close at $19.16 on Friday. Regencell Bioscience reported partial exercise of underwriter... 
Via Benzinga
News headline image
Benchmarks Pivot Higher Ahead of Volatile Week's End ↗
The major indexes rebounded from their pre-market slide soon after the open, with help from big-name tech names, though all three are still on track for weekly losses. 
Via Talk Markets
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Gainers Regencell Bioscience (NASDAQ:RGC) shares rose 175.07% to $17.33 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 277.... 
Via Benzinga
News headline image
38 Stocks Moving In Friday's Mid-Day Session ↗
Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) shares climbed 45.8% to $6.27 after the company presented data from ongoing studies of its preventive vaccine against COVID-19, showing... 
Via Benzinga
News headline image
Why Fate Therapeutics Stock Is Sliding Today ↗
The positive results the company announced after the bell yesterday didn't meet some lofty expectations. 
Via The Motley Fool
News headline image
Mid-Morning Market Update: Markets Rise; Deere Beats Q3 Expectations ↗
Following the market opening Friday, the Dow traded up 0.42% to 35,041.98 while the NASDAQ rose 0.86% to 14,667.29. The S&P also rose, gaining 0.52% to 4,428.90. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Gainers Geovax Labs (NASDAQ:GOVX) shares... 
Via Benzinga
News headline image
11 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers Geovax Labs (NASDAQ:GOVX) stock moved upwards by 74.65% to $7.51. The market value of their outstanding shares is at $47.5 million. Agile Therapeutics (NASDAQ:AGRX... 
Via Benzinga
News headline image
Fate Therapeutics' Stem Cell-Derived NK Lymphoma Candidate Casts Doubt Over Durability Of Response ↗
Fate Therapeutics Inc (NASDAQ: FATE) revealed an early cut of Phase I data for its FT596 and FT516 programs for relapsed / refractory B-cell lymphoma. At the 2021... 
Via Benzinga
News headline image
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS... 
Via Benzinga
News headline image
Fate Stock Collapses As Investors Question Its Cancer Drug's Durability ↗
Fate Therapeutics unveiled mixed results for its lymphoma treatment late Thursday, and Fate stock crumbled in after-hours action. 
Via Investor's Business Daily
News headline image
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow ↗
Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small-... 
Via Benzinga
Topics Initial Public Offering
News headline image
Fate Therapeutics, inc (FATE) Q2 2021 Earnings Call Transcript ↗
FATE earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Did You See What Cathie Wood Bought on Wednesday? ↗
ARK Invest added to its stakes in DraftKings, Fate Therapeutics, and Zoom Video, all of which are trading well below their recent peaks. 
Via The Motley Fool
News headline image
Unusual Options Activity Insight: Fate Therapeutics ↗
On Monday, shares of Fate Therapeutics (NASDAQ:FATE) saw unusual options activity. After the option alert, the stock price moved down to $88. Sentiment: BEARISH Option Type:... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
Via Benzinga
News headline image
Elliott Wave Technical Analysis For Six US Stocks - CDNA, CRWD, FATE, UPS, HDB, SPOT ↗
CareDx, CrowdStrike, Fate Therapeutics, HDFC Bank, Spotify, ​​​​​​​UPS - Daily charts. 
Via Talk Markets
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2021 ↗
Upgrades Deutsche Bank upgraded the previous rating for Marriott Vacations Worldwide Corp (NYSE:VAC) from Hold to Buy. Marriott Vacations earned $0.49 in the first quarter... 
Via Benzinga
News headline image
Fate Therapeutics Stock is Trading Higher on Positive B-Cell Lymphoma Data at ASCO21 ↗
Fate Therapeutics Inc (NASDAQ: FATE) has revealed some new data from an ongoing Phase 1 trial evaluating FT516 for patients with relapsed / refractory B-cell... 
Via Benzinga
News headline image
Fate Therapeutics' iPSC-Derived Cell Therapies Induce Leukemic Blast Clearance, Show Durable Remissions In AML Patients ↗
Fate Therapeutics Inc (NASDAQ: FATE) has announced interim data from Phase 1 data from the Company's off-the-shelf, iPSC-derived natural killer (NK) cell... 
Via Benzinga
News headline image
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes ↗
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Gainers Bionano Genomics (NASDAQ:BNGO) st... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc... 
Via Benzinga
News headline image
Cathie Wood Loads Up $57M In Palantir As Stock Stages Reversal On Q1 Earnings Beat ↗
Cathie Wood-led Ark Investment Management on Tuesday snapped up 2.8 million shares, worth about $56.7 million, in Palantir Technologies Inc (NYSE: PLTR) after the data analytics... 
Via Benzinga
News headline image
Cathie Wood Cuts Apple Stake By 30% And Buys Coinbase, DraftKings ↗
Cathie Wood-led Ark Investment Management shed more shares of Apple Inc (NASDAQ: 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.